In addition, this study investigated a possible molecular mechanism of the anticancer effect of metformin plus SIRT1 inhibitor, tenovin‐6 in NSCLC cells irrespective of LKB1 status. Here, SIRT1 is linked to non-small cell lung carcinoma.